Global Pediatric Growth Hormone Deficiency Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2024 –2031 |
Market Size (Base Year) |
USD 3.45 Billion |
Market Size (Forecast Year) |
USD 13.87 Billion |
CAGR |
|
Major Markets Players |
>全球儿童生长激素缺乏症市场,按类型(后天性、先天性、特发性)、治疗(生长激素注射、其他)、诊断(血液检查、X 光、CT 扫描、MRI、GH 刺激测试、其他)、症状(面容年轻化、青春期延迟、胖乎乎的身材、毛发生长受损、其他)、剂量(注射、其他)、给药途径(皮下、其他)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房)– 行业趋势和预测到 2031 年。
儿童生长激素缺乏症市场分析及规模
垂体肿瘤患病率上升和医疗支出上升是影响市场增长率的主要因素。此外,医疗技术的进步、政府资金的增加以及公共和私人组织为传播眼疾意识而采取的举措不断增加,这些因素将扩大儿童生长激素缺乏症市场。内分泌失调病例数量的增加和与身材矮小相关的病例数量的激增等其他因素将对市场增长率产生积极影响。此外,欠发达国家越来越多的儿科诊断活动和计划将导致儿童生长激素缺乏症市场的扩大。
Data Bridge Market Research 分析,全球儿童生长激素缺乏症市场规模在 2023 年为 34.5 亿美元,到 2031 年可能达到 138.7 亿美元,预计在预测期内的复合年增长率为 19.00%。由于对生长激素诊断血液检测的需求不断增长,“血液检测”在市场诊断领域占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
儿童生长激素缺乏症市场范围和细分
报告指标 |
细节 |
预测期 |
2024 至 2031 年 |
基准年 |
2023 |
历史岁月 |
2022 (可定制为 2016-2021) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
按类型(后天性、先天性、特发性)、治疗(生长激素注射、其他)、诊断(血液检查、X 光、CT 扫描、MRI、GH 刺激测试、其他)、症状(面容年轻化、青春期延迟、体型肥胖、毛发生长受损、其他)、剂量(注射、其他)、给药途径(皮下、其他)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房) |
覆盖国家 |
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa |
Market Players Covered |
Merck KGaA (Germany), Novo Nordisk A/S (Denmark), Genentech, Inc. (U.S.), Ferring B.V. (Switzerland), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Biopartners GmbH (Switzerland), F. Hoffmann-La Roche Ltd. (Switzerland), AnkeBio Co., Ltd. (China), GeneScience Pharmaceuticals Co., Ltd. (China), Teva Pharmaceutical Industries Ltd. (Israel), Ipsen Pharma (France), LG Chem (South Korea) |
Market Opportunities |
|
Market Definition
Growth hormone is a hormone that is required for normal growth and development. The pituitary gland, which is linked to the hypothalamus and located near the base of the brain, produces it. Growth hormone is a hormone that is delivered throughout the body by the bloodstream to assist with a variety of activities, the most significant of which is growth, especially in children. If the pituitary gland or the hypothalamus are destroyed, the amount of growth hormone produced is reduced (this is known as deficiency), resulting in a slowed rate of growth and a reduction in height in the affected kid.
Global Pediatric Growth Hormone Deficiency Market Dynamics
Drivers
- Increasing incidence of pediatric growth hormone deficiency
The rising awareness and improved diagnostic capabilities contribute to the identification of more cases of pediatric growth hormone deficiency. As a result, there is a growing patient pool, driving the demand for growth hormone therapies.
- Advancements in biotechnology and recombinant DNA technology
Innovations in biotechnology, particularly in the development of recombinant growth hormones, have led to safer and more effective treatment options for pediatric growth hormone deficiency. These advancements enhance the overall market outlook and increase the accessibility of advanced therapies.
- Rising emphasis on early diagnosis and treatment
There is an increasing emphasis on early diagnosis and intervention for pediatric health conditions, including growth hormone deficiency. Early identification allows for timely treatment, which can improve outcomes and minimize the impact of the condition on a child's growth and development.
- Growing investment for healthcare facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Strategic Collaborations and Partnerships
Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can lead to the development of innovative treatments, research initiatives, and improved diagnostic tools for pediatric growth hormone deficiency. Strategic partnerships can enhance the overall market ecosystem.
- Focus on Personalized Medicine
The trend toward personalized medicine opens opportunities for tailoring growth hormone therapies based on individual patient characteristics, genetic factors, and treatment responses. Precision medicine approaches may lead to more effective and targeted treatments, minimizing adverse effects and optimizing outcomes for pediatric patients.
Restraints
- High Cost of Treatment
Growth hormone therapies can be expensive, requiring a long-term commitment for effective treatment. The high cost of these therapies may pose a significant financial burden on families and healthcare systems, limiting accessibility for some patients.
- Adverse Effects and Safety Concerns
Some pediatric growth hormone therapies may be associated with side effects, and long-term safety concerns may influence treatment decisions. Safety considerations and potential adverse effects could impact patient compliance and contribute to hesitancy among healthcare providers and parents.
Challenges
- Diagnostic Complexity and Delayed Identification
The complexity of diagnosing pediatric growth hormone deficiency, which often requires specialized testing and careful evaluation, can lead to delays in identification. Limited routine screening may contribute to missed opportunities for early intervention and treatment.
- Limited Treatment Options for Certain Causes
Growth hormone deficiency can have various underlying causes, and treatment options may be limited or less effective in cases where the deficiency is associated with certain genetic or congenital conditions. Developing targeted therapies for specific causes presents a challenge.
本小儿生长激素缺乏症市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关小儿生长激素缺乏症市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。
最新动态
- 2021 年 2 月,辉瑞公司启动了一项 III 期临床试验,以评估生长激素对一组患有普拉德-威利综合征 (PWS) 的日本参与者的有效性和安全性
- 2020 年 10 月,伊拉斯姆斯医疗中心与辉瑞公司、普拉德-威利研究基金会和普拉德-威利基金会合作,启动了一项 III 期临床试验,以评估生长激素治疗 (Genotropin) 对 30 岁或以上患有普拉德-威利综合征的成年人身体和心理健康的影响
全球儿童生长激素缺乏症市场范围
儿童生长激素缺乏症市场根据类型、治疗、诊断、症状、剂量、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
类型
- 获得性
- 先天性
- 特发性
治疗
- 生长激素注射
- 其他的
诊断
- 血液检查
- X 射线
- CT 扫描
- 磁共振成像
- 生长激素刺激试验
- 其他的
症状
- 更显年轻的面容
- 青春期延迟
- 胖乎乎的身材
- 头发生长受损
- 其他的
剂量
- 注射
- 其他的
给药途径
- 皮下
- 其他的
最终用户
- 诊所
- 医院
- 其他的
全球儿童生长激素缺乏症市场区域分析/见解
对儿童生长激素缺乏症市场进行了分析,并按国家、类型、治疗、诊断、症状、剂量、给药途径、最终用户和分销渠道提供了市场规模见解和趋势。
市场报告涉及的国家包括美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非以及中东和非洲其他地区。
北美预计将主导市场,因为该地区拥有主要关键参与者、高可支配收入和发达的医疗保健基础设施。由于研发活动不断增加、医疗保健行业投资不断增加以及政府支持不断增加,预计亚太地区将在预测期内呈现最快的增长速度。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
儿童生长激素缺乏症市场还为您提供每个国家/地区资本设备医疗保健支出增长、儿童生长激素缺乏症市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对儿童生长激素缺乏症市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。
竞争格局和全球儿童生长激素缺乏症市场份额分析
儿童生长激素缺乏症市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对儿童生长激素缺乏症市场的关注有关。
儿童生长激素缺乏症市场的一些主要参与者包括:
- 默克集团(德国)
- 诺和诺德公司(丹麦)
- 基因泰克公司(美国)
- Ferring BV(瑞士)
- 礼来公司 (美国)
- 辉瑞公司(美国)
- 诺华公司(瑞士)
- Biopartners GmbH(瑞士)
- F. Hoffmann-La Roche Ltd.(瑞士)
- 安科生物股份有限公司 (中国)
- 基因科学制药股份有限公司 (中国)
- Teva Pharmaceutical Industries Ltd.(以色列)
- 益普生制药(法国)
- LG化学(韩国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.